Institution
Bridge Pharma (United States)
UScompany
Recent research
- Society & EconomicsOpen access
Systematic evidence synthesis proposing the AI Productivity Contingency Framework (AIPCF). Argues AI is not an automatic firm-productivity or GDP machine; gains depend on complements/intangibles, task content and the jagged technological frontier, firm heterogeneity and adoption,...
- Health & Medicine
Abstract Coamorphous drug systems have received increasing interest owing to their potential to improve the solubility, dissolution, and bioavailability of insoluble drugs. However, coamorphous systems exist in a high-energy state, making them prone to crystallization into stable...